2nd Quarter - Report

BROWNSTEIN HYATT FARBER SCHRECK, LLP for JOHNSON & JOHNSON SERVICES, INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$60,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 21, 2019 $60,000 Replaced
2nd Quarter - Amendment Jul 22, 2019 $60,000 Yes

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Torts TOR

Issues related to civil justice reform

LobbyistCovered position, as disclosed
WILLIAM MOSCHELLA —

Contacted: White House Office; SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES; Vice President of the U.S.

Taxation/Internal Revenue Code TAX

Issues related to corporate tax issues; Implementation of H.R. 1

LobbyistCovered position, as disclosed
ROSEMARY BECCHI —
RUSSELL W. SULLIVAN —

Contacted: Treasury, Dept of; Vice President of the U.S.; HOUSE OF REPRESENTATIVES; SENATE; White House Office

Bills named: H.R. 1 (116th)

Health Issues HCR

Issues related to 340B drug discount program Issues related to patient access S. 1416 - Affordable Prescriptions for Patients Act of 2019

LobbyistCovered position, as disclosed
LAURA JOHNSON BOLLIER —
NADEAM ELSHAMI —
MARC LAMPKIN —
ELIZABETH ANNE MAIER —
WILLIAM MOSCHELLA —
ALFRED MOTTUR —
JEROME MURRAY —
ZACHARY PFISTER New LegDir Rep Larry Kissell; SenLegAsst Rep Larry Kissell; LegAsst Rep Larry Kissell; LegCorrespondent Rep Larry Kissell; LegCorrespondent Rep Brad Ellsworth; StaffAsst Rep Brad Ellsworth; LegIntern Sen Evan Bayh

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Vice President of the U.S.; White House Office; Treasury, Dept of

Bills named: S. 1416 (116th)

Consumer Issues/Safety/Products CSP

Issues related to pseudoephedrine Issues related to the regulation of cosmetic products Safe use of OTC products Matters related to American Medical Association Resolution 208(A-16) adopted April 2016

LobbyistCovered position, as disclosed
WILLIAM MOSCHELLA —
ALFRED MOTTUR —

Contacted: White House Office; SENATE; Vice President of the U.S.; Treasury, Dept of; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.